{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T00:58:49Z","timestamp":1772758729026,"version":"3.50.1"},"reference-count":15,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2011,8,1]],"date-time":"2011-08-01T00:00:00Z","timestamp":1312156800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pulmonary Pharmacology & Therapeutics"],"published-print":{"date-parts":[[2011,8]]},"DOI":"10.1016\/j.pupt.2011.03.004","type":"journal-article","created":{"date-parts":[[2011,4,8]],"date-time":"2011-04-08T13:08:12Z","timestamp":1302268092000},"page":"373-376","source":"Crossref","is-referenced-by-count":5,"title":["Changes of clinical outcomes and health care resources in moderate and in severe COPD treated uniquely with tiotropium 18\u00a0mcg od for twenty-four months"],"prefix":"10.1016","volume":"24","author":[{"given":"R.W.","family":"Dal Negro","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Bonadiman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Micheletto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Tognella","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Turati","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Turco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.pupt.2011.03.004_bib1","unstructured":"Global Initiative for Chronic Obstructive Lung Disease. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. http:\/\/www.goldcopd.com(Updated 2006)."},{"key":"10.1016\/j.pupt.2011.03.004_bib2","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1159\/000050456","article-title":"Epidemiology of chronic obstructive pulmonary disease (COPD)","volume":"68","author":"Viegi","year":"2001","journal-title":"Respiration"},{"key":"10.1016\/j.pupt.2011.03.004_bib3","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1056\/NEJMoa063070","article-title":"Salmeterol and fluticasone propionate in chronic obstructive pulmonary disease","volume":"356","author":"Calverly","year":"2007","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.pupt.2011.03.004_bib4","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1056\/NEJMoa0805800","article-title":"A\u00a04-year trial of tiotropium in chronic obstructive pulmonary disease","volume":"359","author":"Tashkin","year":"2008","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.pupt.2011.03.004_bib5","doi-asserted-by":"crossref","first-page":"1616","DOI":"10.1056\/NEJMe0807387","article-title":"COPD and declining FEV1-time to divide and conquer?","volume":"359","author":"Reilly","year":"2008","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.pupt.2011.03.004_bib6","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1164\/rccm.200712-1869OC","article-title":"Effect of pharmacotherapy on rate of decline of lung function in chronic obstructive pulmonary disease: results from the TORCH study","volume":"178","author":"Celli","year":"2008","journal-title":"Am J Respir Crit Care Med"},{"issue":"9696","key":"10.1016\/j.pupt.2011.03.004_bib7","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1016\/S0140-6736(09)61298-8","article-title":"Effect of tiotropium on outcomes in patients with moderate chronic obstructive pulmonary disease (UPLIFT): a prespecified subgroup analysis of a randomised controlled trial","volume":"374","author":"Decramer","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/j.pupt.2011.03.004_bib8","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1186\/1465-9921-10-59","article-title":"Efficacy of salmeterol\/fluticasone propionate by GOLD stage of chronic obstructive pulmonary disease: analysis from the randomised, placebo-controlled TORCH study","volume":"10","author":"Jenkins","year":"2009","journal-title":"Respir Res"},{"issue":"15","key":"10.1016\/j.pupt.2011.03.004_bib9","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1056\/NEJMoa0805800","article-title":"A\u00a0four-year trial of tiotropium in chronic obstructive pulmonary disease","volume":"359","author":"Tashkin","year":"2008","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.pupt.2011.03.004_bib10","first-page":"1007","article-title":"Gestione automatizzata di alcuni flussi informativi nell\u2019ambito della patologia respiratoria. Atti 7^ Congr. Naz","author":"Dal Negro","year":"1984","journal-title":"SIFPR"},{"key":"10.1016\/j.pupt.2011.03.004_bib11","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1164\/rccm.200707-973OC","article-title":"The prevention of chronic obstructive pulmonary disease exacerbations by salmetero\/fluticasone propionate or tiotropium bromide","volume":"177","author":"Wedzicha","year":"2008","journal-title":"Am J Respir Crit Care Med"},{"issue":"1","key":"10.1016\/j.pupt.2011.03.004_bib12","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1183\/09031936.00127809","article-title":"Tiotropium as a first maintenance therapy in COPD: secondary analysis of the OPLIFT study","volume":"36","author":"Troosters","year":"2010","journal-title":"Eur Respir J"},{"issue":"11","key":"10.1016\/j.pupt.2011.03.004_bib13","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1016\/j.rmed.2010.07.016","article-title":"COPD in young patients: a pre-specified analysis of the four-year trial of the tiotropium (UPLIFT)","volume":"104","author":"Morice","year":"2010","journal-title":"Respir Med"},{"issue":"26","key":"10.1016\/j.pupt.2011.03.004_bib14","doi-asserted-by":"crossref","first-page":"2689","DOI":"10.1056\/NEJMra030415","article-title":"-Management of chronic obstructive pulmonary disease","volume":"350","author":"Sutherland","year":"2004","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.pupt.2011.03.004_bib15","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1136\/thx.2006.063271","article-title":"Tiotropium for stable chronic obstructive pulmonary disease: a meta-analysis","volume":"61","author":"Barr","year":"2006","journal-title":"Thorax"}],"container-title":["Pulmonary Pharmacology & Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S109455391100040X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S109455391100040X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,6,9]],"date-time":"2019-06-09T17:26:22Z","timestamp":1560101182000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S109455391100040X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,8]]},"references-count":15,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2011,8]]}},"alternative-id":["S109455391100040X"],"URL":"https:\/\/doi.org\/10.1016\/j.pupt.2011.03.004","relation":{},"ISSN":["1094-5539"],"issn-type":[{"value":"1094-5539","type":"print"}],"subject":[],"published":{"date-parts":[[2011,8]]}}}